Sadra Medical raises $30M for aortic valve replacement
Sadra Medical, which is developing a procedure to replace the aortic valve (for the less medically-savvy, that’s part of your heart), has raised $30 million in a third round of funding. The Campbell, Calif., company dubs its procedure “percutaneous aortic valve replacement,” and it involves placing the prosthetic valve in a patient’s heart by threading a catheter through their arteries. The round was led by Accuitive Medical Ventures, with participation from previous investors Boston Scientific,… Continue Reading
Neovista sees $18M to treat eye disorders
Neovista, a Fremont, Calif.-based biotech company specializing in eye diseases, says it raised $18 million in a fourth round of funding to commercialize its new device. The money came from Accuitive Medical Ventures, Carlyle Group, Essex Woodlands Health Ventures, MPM Capital, SV Life Sciences and Versant Ventures.
The company says the money should be enough to see the device through to approval by the Food and Drug Administration in 2010. The product has already been cleared… Continue Reading
Nevro raises $22 million for pain therapy
Nevro Corp. has raised $22 million in a first round of funding. The Palo Alto, Calif. company is conducting clinical trials for its neuromodulation therapy for chronic pain. New investor Accuitive Medical Ventures joined return investors Aberdare Ventures, Bay City Capital, Mayo Clinic, MPM Capital and Three Arch Partners. Nevro raised a $5.5 million seed round in 2006.
MyoScience raises $10.4M for aesthetic medicine
MyoScience, a stealth-mode medical company based in Redwood City, Calif., has taken $10.4 million in a second funding for continuing clinical trials.
The company has not yet disclosed exactly what use its aesthetic devices will have, although CEO Lisa Elkins hinted that aging eyes and skin might be the target to VentureWire, which first reported the funding.
The funding was led by Nexus Medical Partners, with participation from Accuitive Medical Ventures, De Novo Ventures and Saratoga Ventures…. Continue Reading
Life-science briefing: Tuesday, March 25, 2008
TODAY’S HEADLINES:
Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes in $24M of $80M fund (peHUB)
Halsa Pharma gets $250K for “natural” obesity-control treatment (release)
Diagnostics provider Lab21 acquires NPTech (peHUB)
Galil Medical names Martin Emerson CEO (release)
Antibody-discovery startup Adimab raises new funding – Lebanon,… Continue Reading
Life sciences briefing: Wednesday, Dec. 5, 2007
Featured companies: AxoGen, Cognition Therapeutics, Ester Neurosciences, Gene Security Network, HealthTalk, MPM Capital, Revolution Health, SparkPeople
UPDATING: Expanded items on AxoGen, Ester and Cognition. Posted full items on MPM (link) and Gene Security Network (link).
AxoGen raises $12M for nerve regeneration — AxoGen, an Alachua, Fla., biotech focused on developing grafts for damaged “peripheral” nerves, raised $12.1 million in a third funding round. Investors included Accuitive Medical Ventures, Cardinal Partners, De Novo Ventures and Springboard Capital II.
AxoGen develops tissue… Continue Reading
Funding roundup: Announcements that got away
Although I try to stay on top of events in the life sciences, announcements do sometimes manage to slip through the cracks. Some days, in fact, I end up triaging. Because the roots of this site — not to mention many of its readers — are in Silicon Valley, Bay Area events are a priority. Then come announcements from the rest of the U.S., then Asia, then Europe. Also, smaller or partial fundings tend to… Continue Reading
WaveTec Vision Systems takes in $13M for intraocular lens replacement
WaveTec Vision Systems of Aliso Viejo, Calif., raised $13 million in a second round of funding, PEHub reports. The company is developing a system to improve patient outcomes in intraocular lens replacement surgeries. The deal was led by Accuitive Medical Ventures and De Novo Ventures, who were joined by existing investor Versant Ventures.
NeoVista, a co. targeting age-related macular degeneration, raises $41M
NeoVista, a Fremont ophthalmic device company focusing on the treatment of wet age-related macular degeneration, said it has raised a third $41 million round of venture financing.
The company is in the early stages of testing its technology, and it won’t hit the market until around 2010 at the earliest. Separately, VentureWire reports a comment from the company’s VP of marketing that the company had received interest from a company about a possible acquisition.
New investors Essex… Continue Reading